News and Trends 8 Dec 2022 MetrioPharm reveals COVID-19 study data …profile in several clinical trials without severe drug-related adverse events or potential for adverse drug-drug interactions. It is suitable for elderly and multi-morbid patients with a wide range of concomitant… December 8, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 7 Oct 2022 Beyond Biotech podcast 17: BIO-Europe, National Hemophilia Foundation …with Travis McCready. BIO-Europe set to start in Leipzig BIO-Europe, one of the biggest biotech events in Europe, is returning with a three day in-person event, followed by a three-day… October 7, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Opinion 1 Nov 2023 Could this be the start of a new era for PI3K drugs? …example, mouse model data presented at the event showed PI3Ka activation during a reperfusion procedure after a stent operation prevents infarctions. Activation of PI3Ka also led to regeneration of nerves… November 1, 2023 - 7 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
In Depth 30 Oct 2024 Could next-generation “switchable” CAR-T cells help improve the safety and efficacy of CAR-T therapies? …therapies. Patients who did experience CRS or ICANS had a shorter duration of these events, limited to around two or three days, compared to five to 17 days for patients… October 30, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 19 Jun 2024 MASH candidates make a splash after first drug approval …“serious adverse events” were reported during the trial. Another California-based biopharma that is developing a drug for MASH is 89bio. Its phase 3 candidate pegozafermin is similar to Akero’s EFX…. June 19, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 14 Apr 2023 Researchers explain how some lung tumors avoid immunotherapy …oncogene MYC, which leads to a cascade of events that prevent the action of the gamma interferon inside the cell. Experimental results show this could be a strong and reliable… April 14, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 13 Aug 2018 Orchard Therapeutics Raises €132M to Develop Gene Therapies …and a genetic disorder that prevents the immune system from warding off infections, respectively. The Series C round was led by Deerfield Management, a hedge fund sponsor focused on the… August 13, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
Inside Labiotech 23 May 2019 See you Labiotech, it has been an awesome ride 🚀 …as usual. We’ve taken the time to make sure that no operations or processes are disturbed by the transition. Continue to expect amazing content, cool events, and a growing membership!… May 23, 2019 - 4 minutesmins - By Philip Hemme Share WhatsApp Twitter Linkedin Email
News and Trends 10 Feb 2023 Europe approves childhood epilepsy treatment …compared to placebo. The most common treatment-emergent adverse events were decreased appetite, somnolence, fatigue, and pyrexia (fever). No cases of valvular heart disease or pulmonary arterial hypertension were observed. Rima… February 10, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 7 Jun 2024 5 universities offering a Masters in biotechnology in France …training students in various sectors of Science and Technology for Health. It provides courses and events on health technologies, and access to fellowships. The graduate schools involving specific research areas,… June 7, 2024 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 5 Dec 2017 Europe’s Brightest Stars: The 9 Best Biotech Companies of 2017 …therapy could be on the market as soon as next year. Who are the best biotech companies of 2017? We selected the nine shiniest European stars based on financial events… December 5, 2017 - 6 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 28 Jul 2023 Could a natural sweetener from hydrangeas treat Alzheimer’s disease? …prevents Aβ-induced neurotoxicity and attributed this to the reduced Aβ aggregates. The study revealed that phyllodulcin reduced the memory impairments caused by the accumulation of amyloid proteins. The hippocampus is… July 28, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email